Prospective Study
Copyright ©2014 Baishideng Publishing Group Inc.
World J Gastroenterol. Sep 14, 2014; 20(34): 12260-12268
Published online Sep 14, 2014. doi: 10.3748/wjg.v20.i34.12260
Table 3 Risk factors for biliary candidiasis n (%)
Risk factorsNo biliary candidiasis (n = 89)Biliary candidiasis (n = 38)P valueExp(B)95%CI for exp(B)
Age58.3 ± 15.664.7 ± 15.00.0361.0341.002-1.067
Malignancy20 (22.5)15 (39.5)0.2420.4940.152-1.609
Cholangio-carcinoma8 (9.0)7 (18.4)0.3720.4970.107-2.310
Immunosup-pression42 (47.2)26 (68.4)0.0580.4030.158-1.031
ICU2 (2.2)2 (5.3)1.000
Mechanical ventilation2 (2.2)1 (2.6)1.0002.3E+9
Antibiotic therapy42 (47.2)26 (68.4)0.2000.5300.201-1.399
Long-term antibiotic therapy (> 7 d)9 (10.1)11 (28.9)0.0890.3540.107-1.170
Previous EST51 (57.3)25 (65.8)0.0120.2460.082-0.739
Previous ERCP53 (59.6)26 (68.4)0.5741.3180.504-3.444